Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Galli

Showing results (41-50 of 217) with videos related to

Pageof 22
Sort By:
Haematologica|May 16, 2002
Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosisFranco Piovella, Luciano Crippa, Marisa Barone, et al.
Cancer|April 30, 2013
Clinical, virologic, and immunologic outcomes in lymphoma survivors and in cancer-free, HIV-1-infected patients: a matched cohort studyVincenzo Spagnuolo, Giovanna Travi, Laura Galli, et al.
Antiviral Therapy|October 1, 2004
The NIQ of lopinavir is predictive of a 48-week virological response in highly treatment-experienced HIV-1-infected subjects treated with a lopinavir/ritonavir-containing regimenAntonella Castagna, Nicola Gianotti, Laura Galli, et al.
Journal of Medical Virology|December 22, 2007
HIV-1 replication capacity and genotype changes in patients undergoing treatment interruption or lamivudine monotherapyNicola Gianotti, Simon Tiberi, Stefano Menzo, et al.
The New Microbiologica|September 7, 2007
Liver function parameters in HIV/HCV co-infected patients treated with amprenavir and ritonavir and correlation with plasma levelsVincenzo Spagnuolo, Gianluca Gentilini, Anna De Bona, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 13, 2005
Liver fibrosis in HIV-positive patients with hepatitis C virus: role of persistently normal alanine aminotransferase levelsCaterina Uberti-Foppa, Anna De Bona, Laura Galli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2005
Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infectionFlavia B Lillo, Sara Lodini, Davide Ferrari, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2006
The 118I reverse transcriptase mutation is the only independent genotypic predictor of virologic failure to a stavudine-containing salvage therapy in HIV-1-infected patientsNicola Gianotti, Laura Galli, Enzo Boeri, et al.
Cancers|March 29, 2023
Survival in People Living with HIV with or without Recurrence of Hepatocellular Carcinoma after Invasive TherapyCostanza Bertoni, Laura Galli, Riccardo Lolatto, et al.
HLA|November 14, 2023
Impact of predicted HLA class I immunopeptidome on viral reservoir in a cohort of people living with HIV in ItalyPier Edoardo Rovatti, Camilla Muccini, Marco Punta, et al.
Pageof 22

Showing results (41-50 of 217) with videos related to

Sort By:
Pageof 22
Haematologica|May 16, 2002
Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosisFranco Piovella, Luciano Crippa, Marisa Barone, et al.
Cancer|April 30, 2013
Clinical, virologic, and immunologic outcomes in lymphoma survivors and in cancer-free, HIV-1-infected patients: a matched cohort studyVincenzo Spagnuolo, Giovanna Travi, Laura Galli, et al.
Antiviral Therapy|October 1, 2004
The NIQ of lopinavir is predictive of a 48-week virological response in highly treatment-experienced HIV-1-infected subjects treated with a lopinavir/ritonavir-containing regimenAntonella Castagna, Nicola Gianotti, Laura Galli, et al.
Journal of Medical Virology|December 22, 2007
HIV-1 replication capacity and genotype changes in patients undergoing treatment interruption or lamivudine monotherapyNicola Gianotti, Simon Tiberi, Stefano Menzo, et al.
The New Microbiologica|September 7, 2007
Liver function parameters in HIV/HCV co-infected patients treated with amprenavir and ritonavir and correlation with plasma levelsVincenzo Spagnuolo, Gianluca Gentilini, Anna De Bona, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 13, 2005
Liver fibrosis in HIV-positive patients with hepatitis C virus: role of persistently normal alanine aminotransferase levelsCaterina Uberti-Foppa, Anna De Bona, Laura Galli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2005
Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infectionFlavia B Lillo, Sara Lodini, Davide Ferrari, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2006
The 118I reverse transcriptase mutation is the only independent genotypic predictor of virologic failure to a stavudine-containing salvage therapy in HIV-1-infected patientsNicola Gianotti, Laura Galli, Enzo Boeri, et al.
Cancers|March 29, 2023
Survival in People Living with HIV with or without Recurrence of Hepatocellular Carcinoma after Invasive TherapyCostanza Bertoni, Laura Galli, Riccardo Lolatto, et al.
HLA|November 14, 2023
Impact of predicted HLA class I immunopeptidome on viral reservoir in a cohort of people living with HIV in ItalyPier Edoardo Rovatti, Camilla Muccini, Marco Punta, et al.
Pageof 22